secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCorRx Inc. (BICX)
CIK:        0001443863
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001477932-24-000065
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCorRx President Brady Granier resigns; Louis Lucido appointed as President
-----------------------------------------------------------------------------

- Brady Granier resigned as President of BioCorRx and CEO of BioCorRx Pharmaceuticals, effective Jan 31, 2024; remains on board.
- Louis Lucido appointed Interim President from Jan 5, 2024, then President from Feb 1, 2024; remains board member.
- Lucido to receive $200,000 annual compensation paid in equity monthly (~$16,667 in shares based on 3-day avg closing price).
- Lucido, 75, formerly COO of DoubleLine Group and founding partner; director since March 2019.
- Granier's resignation not due to any disagreement with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1443863/000147793224000065/0001477932-24-000065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1443863/000147793224000065/bicx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-000065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer